Other Species / Isoforms
  NCL (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K9-ac
VKLAKAGkNQGDPkk
1 56
NCL (human) VKLAKAGkNQGDPkk K9-ac
NCL (mouse) VKLAKAGkTHGEAkk K9-ac
NCL (rat) VKLAKAGKTHGESKK K9
NCL iso6 (rat) VKLAKAGKTHGESKK K9
NCL (cow) VKLAKAGKNQGDSKK K9
K15-ac
GkNQGDPkkMAPPPK
1 57
NCL (human) GkNQGDPkkMAPPPK K15-ac
NCL (mouse) GkTHGEAkkMAPPPK K15-ac
NCL (rat) GKTHGESKKMAPPPK K15
NCL iso6 (rat) GKTHGESKKMAPPPK K15
NCL (cow) GKNQGDSKKMAPPPK K15
K16-ac
kNQGDPkkMAPPPKE
0 8
NCL (human) kNQGDPkkMAPPPKE K16-ac
NCL (mouse) kTHGEAkkMAPPPKE K16-ac
NCL (rat) KTHGESKKMAPPPKE K16
NCL iso6 (rat) KTHGESKKMAPPPKE K16
NCL (cow) KNQGDSKKMAPPPKE K16
S28-p
PKEVEEDsEDEEMsE
Upstream
Downstream
1 52
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • cell cycle regulation
  • cell growth, induced
Treatment
  • anti-CD3
NCL (human) PKEVEEDsEDEEMsE S28-p
NCL (mouse) PKEVEEDsEDEEMsE S28-p
NCL (rat) PKEVEEDsEDEEMsE S28-p
NCL iso6 (rat) PKEVEEDSEDEEMSE S28
NCL (cow) PKEVEEDSEDEEMSE S28
S34-p
DsEDEEMsEDEEDDs
Upstream
Downstream
2 49
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • cell cycle regulation
  • cell growth, induced
Treatment
  • anti-CD3
NCL (human) DsEDEEMsEDEEDDs S34-p
NCL (mouse) DsEDEEMsEDEDDss S34-p
NCL (rat) DsEDEEMsEDEDDss S34-p
NCL iso6 (rat) DSEDEEMSEDEDDSS S34
NCL (cow) DSEDEEMSEDEDDES S34
D40
MsEDEEDDssGEEVV
0 19
NCL (human) MsEDEEDDssGEEVV D40
NCL (mouse) MsEDEDDssGEEEVV S40-p
NCL (rat) MsEDEDDssGEEEVV S40-p
NCL iso6 (rat) MSEDEDDSSGEEEVV S40
NCL (cow) MSEDEDDESSGEEVV E40
S41-p
sEDEEDDssGEEVVI
Upstream
0 46
Treatment
  • anti-CD3
  • SII_angiotensin_2
NCL (human) sEDEEDDssGEEVVI S41-p
NCL (mouse) sEDEDDssGEEEVVI S41-p
NCL (rat) sEDEDDssGEEEVVI S41-p
NCL iso6 (rat) SEDEDDSSGEEEVVI S41
NCL (cow) SEDEDDESSGEEVVI S41
S42-p
EDEEDDssGEEVVIP
Upstream
0 30
Treatment
  • CXCL12
  • SII_angiotensin_2
NCL (human) EDEEDDssGEEVVIP S42-p
NCL (mouse) EDEDDssGEEEVVIP G42
NCL (rat) EDEDDssGEEEVVIP G42
NCL iso6 (rat) EDEDDSSGEEEVVIP G42
NCL (cow) EDEDDESSGEEVVIP S42
T59
KGKKAAATsAkkVVV
0 1
NCL (human) KGKKAAATsAkkVVV T59
NCL (mouse) KGKKATTtPAKKVVV T59-p
NCL (rat) KGKKATTTPAKKVVV T59
NCL iso6 (rat) KGKKATTTPAKKVVV T59
NCL (cow) KGKKAATTPAKKMVV T59
S60-p
GKKAAATsAkkVVVs
0 1
NCL (human) GKKAAATsAkkVVVs S60-p
NCL (mouse) GKKATTtPAKKVVVs P60
NCL (rat) GKKATTTPAKKVVVS P60
NCL iso6 (rat) GKKATTTPAKKVVVS P60
NCL (cow) GKKAATTPAKKMVVS P60
K62-ac
KAAATsAkkVVVsPt
0 16
NCL (human) KAAATsAkkVVVsPt K62-ac
NCL (mouse) KATTtPAKKVVVsQT K62
NCL (rat) KATTTPAKKVVVSQT K62
NCL iso6 (rat) KATTTPAKKVVVSQT K62
NCL (cow) KAATTPAKKMVVSPt K62
K63-ac
AAATsAkkVVVsPtk
1 0
NCL (human) AAATsAkkVVVsPtk K63-ac
NCL (mouse) ATTtPAKKVVVsQTk K63
NCL (rat) ATTTPAKKVVVSQTK K63
NCL iso6 (rat) ATTTPAKKVVVSQTK K63
NCL (cow) AATTPAKKMVVSPtK K63
K63-ub
AAATsAkkVVVsPtk
0 1
NCL (human) AAATsAkkVVVsPtk K63-ub
NCL (mouse) ATTtPAKKVVVsQTk K63
NCL (rat) ATTTPAKKVVVSQTK K63
NCL iso6 (rat) ATTTPAKKVVVSQTK K63
NCL (cow) AATTPAKKMVVSPtK K63
S67-p
sAkkVVVsPtkkVAV
Upstream
0 94
Treatment
  • metastatic potential
NCL (human) sAkkVVVsPtkkVAV S67-p
NCL (mouse) PAKKVVVsQTkkAAV S67-p
NCL (rat) PAKKVVVSQTKKAAV S67
NCL iso6 (rat) PAKKVVVSQTKKAAV S67
NCL (cow) PAKKMVVSPtKKVAV S67
T69-p
kkVVVsPtkkVAVAt
Upstream
0 55
Treatment
  • metastatic potential
NCL (human) kkVVVsPtkkVAVAt T69-p
NCL (mouse) KKVVVsQTkkAAVPt T69
NCL (rat) KKVVVSQTKKAAVPT T69
NCL iso6 (rat) KKVVVSQTKKAAVPT T69
NCL (cow) KKMVVSPtKKVAVAT T69-p
K70-ac
kVVVsPtkkVAVAtP
1 65
NCL (human) kVVVsPtkkVAVAtP K70-ac
NCL (mouse) KVVVsQTkkAAVPtP K70-ac
NCL (rat) KVVVSQTKKAAVPTP K70
NCL iso6 (rat) KVVVSQTKKAAVPTP K70
NCL (cow) KMVVSPtKKVAVATP K70
K70-ub
kVVVsPtkkVAVAtP
0 1
NCL (human) kVVVsPtkkVAVAtP K70-ub
NCL (mouse) KVVVsQTKkAAVPtP K70
NCL (rat) KVVVSQTKKAAVPTP K70
NCL iso6 (rat) KVVVSQTKKAAVPTP K70
NCL (cow) KMVVSPtKKVAVATP K70
K71-ac
VVVsPtkkVAVAtPA
0 9
NCL (human) VVVsPtkkVAVAtPA K71-ac
NCL (mouse) VVVsQTkkAAVPtPA K71-ac
NCL (rat) VVVSQTKKAAVPTPA K71
NCL iso6 (rat) VVVSQTKKAAVPTPA K71
NCL (cow) MVVSPtKKVAVATPA K71
K71-m1
VVVsPtkkVAVAtPA
0 12
NCL (human) VVVsPtkkVAVAtPA K71-m1
NCL (mouse) VVVsQTkKAAVPtPA K71
NCL (rat) VVVSQTKKAAVPTPA K71
NCL iso6 (rat) VVVSQTKKAAVPTPA K71
NCL (cow) MVVSPtKKVAVATPA K71
K71-ub
VVVsPtkkVAVAtPA
0 2
NCL (human) VVVsPtkkVAVAtPA K71-ub
NCL (mouse) VVVsQTkKAAVPtPA K71
NCL (rat) VVVSQTKKAAVPTPA K71
NCL iso6 (rat) VVVSQTKKAAVPTPA K71
NCL (cow) MVVSPtKKVAVATPA K71
T76-p
tkkVAVAtPAkkAAV
Upstream
Downstream
4 51
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell growth, induced
  • cell motility, induced
Kinase, in vitro:
  • CDC7 (human)
  • CDK2 (human)
Treatment
  • adriamycin
  • CXCL12
  • ischemia
  • nocodazole
  • ZK-Thiazolidinone
NCL (human) tkkVAVAtPAkkAAV T76-p
NCL (mouse) TkkAAVPtPAkKAAV T76-p
NCL (rat) TKKAAVPTPAkKAAV T76
NCL iso6 (rat) TKKAAVPTPAKKAAV T76
NCL (cow) tKKVAVATPAKKAVV T76
K79-ac
VAVAtPAkkAAVtPG
1 31
NCL (human) VAVAtPAkkAAVtPG K79-ac
NCL (mouse) AAVPtPAkKAAVtPG K79-ac
NCL (rat) AAVPTPAkKAAVTPG K79-ac
NCL iso6 (rat) AAVPTPAKKAAVTPG K79
NCL (cow) VAVATPAKKAVVTPG K79
K79-ub
VAVAtPAkkAAVtPG
0 2
NCL (human) VAVAtPAkkAAVtPG K79-ub
NCL (mouse) AAVPtPAKKAAVtPG K79
NCL (rat) AAVPTPAKKAAVTPG K79
NCL iso6 (rat) AAVPTPAKKAAVTPG K79
NCL (cow) VAVATPAKKAVVTPG K79
K79-sc
VAVAtPAkkAAVtPG
0 1
NCL (human) VAVAtPAkkAAVtPG K79-sc
NCL (mouse) AAVPtPAKKAAVtPG K79
NCL (rat) AAVPTPAKKAAVTPG K79
NCL iso6 (rat) AAVPTPAKKAAVTPG K79
NCL (cow) VAVATPAKKAVVTPG K79
K80-ac
AVAtPAkkAAVtPGk
1 0
NCL (human) AVAtPAkkAAVtPGk K80-ac
NCL (mouse) AVPtPAkKAAVtPGk K80
NCL (rat) AVPTPAkKAAVTPGK K80
NCL iso6 (rat) AVPTPAKKAAVTPGK K80
NCL (cow) AVATPAKKAVVTPGK K80
K80-m1
AVAtPAkkAAVtPGk
0 4
NCL (human) AVAtPAkkAAVtPGk K80-m1
NCL (mouse) AVPtPAkKAAVtPGk K80
NCL (rat) AVPTPAkKAAVTPGK K80
NCL iso6 (rat) AVPTPAKKAAVTPGK K80
NCL (cow) AVATPAKKAVVTPGK K80
T84-p
PAkkAAVtPGkkAAA
Upstream
Downstream
1 18
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell growth, induced
Treatment
  • MG132_withdrawal
  • nocodazole
  • ZK-Thiazolidinone
NCL (human) PAkkAAVtPGkkAAA T84-p
NCL (mouse) PAkKAAVtPGkKAVA T84-p
NCL (rat) PAkKAAVTPGKKAAA T84
NCL iso6 (rat) PAKKAAVTPGKKAAA T84
NCL (cow) PAKKAVVTPGKKAAA T84
K87-ac
kAAVtPGkkAAAtPA
1 83
NCL (human) kAAVtPGkkAAAtPA K87-ac
NCL (mouse) KAAVtPGkKAVAtPA K87-ac
NCL (rat) KAAVTPGKKAAATPA K87
NCL iso6 (rat) KAAVTPGKKAAATPA K87
NCL (cow) KAVVTPGKKAAAMPA K87
K87-sc
kAAVtPGkkAAAtPA
0 1
NCL (human) kAAVtPGkkAAAtPA K87-sc
NCL (mouse) KAAVtPGKKAVAtPA K87
NCL (rat) KAAVTPGKKAAATPA K87
NCL iso6 (rat) KAAVTPGKKAAATPA K87
NCL (cow) KAVVTPGKKAAAMPA K87
K88-ac
AAVtPGkkAAAtPAk
1 3
NCL (human) AAVtPGkkAAAtPAk K88-ac
NCL (mouse) AAVtPGkKAVAtPAk K88
NCL (rat) AAVTPGKKAAATPAK K88
NCL iso6 (rat) AAVTPGKKAAATPAK K88
NCL (cow) AVVTPGKKAAAMPAK K88
T92-p
PGkkAAAtPAkktVt
Upstream
0 15
Treatment
  • nocodazole
  • ZK-Thiazolidinone
NCL (human) PGkkAAAtPAkktVt T92-p
NCL (mouse) PGkKAVAtPAkKNIt T92-p
NCL (rat) PGKKAAATPAKKAVT T92
NCL iso6 (rat) PGKKAAATPAKKAVT T92
NCL (cow) PGKKAAAMPAKKTVT M92
K95-ac
kAAAtPAkktVtPAk
0 8
NCL (human) kAAAtPAkktVtPAk K95-ac
NCL (mouse) KAVAtPAkKNItPAk K95-ac
NCL (rat) KAAATPAKKAVTPAk K95
NCL iso6 (rat) KAAATPAKKAVTPAK K95
NCL (cow) KAAAMPAKKTVTPAK K95
K96-m1
AAAtPAkktVtPAkA
0 8
NCL (human) AAAtPAkktVtPAkA K96-m1
NCL (mouse) AVAtPAkKNItPAkV K96
NCL (rat) AAATPAKKAVTPAkV K96
NCL iso6 (rat) AAATPAKKAVTPAKV K96
NCL (cow) AAAMPAKKTVTPAKA K96
T97-p
AAtPAkktVtPAkAV
0 2
NCL (human) AAtPAkktVtPAkAV T97-p
NCL (mouse) VAtPAkKNItPAkVI N97
NCL (rat) AATPAKKAVTPAkVV A97
NCL iso6 (rat) AATPAKKAVTPAKVV A97
NCL (cow) AAMPAKKTVTPAKAV T97
T99-p
tPAkktVtPAkAVtt
Upstream
0 28
Treatment
  • nocodazole
NCL (human) tPAkktVtPAkAVtt T99-p
NCL (mouse) tPAkKNItPAkVIPt T99-p
NCL (rat) TPAKKAVTPAkVVPT T99
NCL iso6 (rat) TPAKKAVTPAKVVPT T99
NCL (cow) MPAKKTVTPAKAVVT T99
K102-ac
kktVtPAkAVttPGk
Upstream
1 33
Treatment
  • MS275
  • vorinostat
NCL (human) kktVtPAkAVttPGk K102-ac
NCL (mouse) kKNItPAkVIPtPGK K102-ac
NCL (rat) KKAVTPAkVVPTPGK K102-ac
NCL iso6 (rat) KKAVTPAKVVPTPGK K102
NCL (cow) KKTVTPAKAVVTPGK K102
K102-ub
kktVtPAkAVttPGk
0 5
NCL (human) kktVtPAkAVttPGk K102-ub
NCL (mouse) kKNItPAKVIPtPGK K102
NCL (rat) KKAVTPAKVVPTPGK K102
NCL iso6 (rat) KKAVTPAKVVPTPGK K102
NCL (cow) KKTVTPAKAVVTPGK K102
T105-p
VtPAkAVttPGkkGA
0 6
NCL (human) VtPAkAVttPGkkGA T105-p
NCL (mouse) ItPAkVIPtPGKKGA P105
NCL (rat) VTPAkVVPTPGKKGA P105
NCL iso6 (rat) VTPAKVVPTPGKKGA P105
NCL (cow) VTPAKAVVTPGKKGA V105
T106-p
tPAkAVttPGkkGAt
Upstream
0 17
Treatment
  • MG132
  • MG132_withdrawal
  • nocodazole
  • ZK-Thiazolidinone
NCL (human) tPAkAVttPGkkGAt T106-p
NCL (mouse) tPAkVIPtPGKKGAA T106-p
NCL (rat) TPAkVVPTPGKKGAA T106
NCL iso6 (rat) TPAKVVPTPGKKGAA T106
NCL (cow) TPAKAVVTPGKKGAT T106
K109-ac
kAVttPGkkGAtPGk
1 42
NCL (human) kAVttPGkkGAtPGk K109-ac
NCL (mouse) kVIPtPGKKGAAQAk K109
NCL (rat) kVVPTPGKKGAAQAk K109
NCL iso6 (rat) KVVPTPGKKGAAQAK K109
NCL (cow) KAVVTPGKKGATPGK K109
K110-ac
AVttPGkkGAtPGkA
1 8
NCL (human) AVttPGkkGAtPGkA K110-ac
NCL (mouse) VIPtPGKKGAAQAkA K110
NCL (rat) VVPTPGKKGAAQAkA K110
NCL iso6 (rat) VVPTPGKKGAAQAKA K110
NCL (cow) AVVTPGKKGATPGKA K110
K110-ub
AVttPGkkGAtPGkA
0 1
NCL (human) AVttPGkkGAtPGkA K110-ub
NCL (mouse) VIPtPGKKGAAQAkA K110
NCL (rat) VVPTPGKKGAAQAkA K110
NCL iso6 (rat) VVPTPGKKGAAQAKA K110
NCL (cow) AVVTPGKKGATPGKA K110
T113-p
tPGkkGAtPGkALVA
Upstream
0 13
Treatment
  • ischemia
  • nocodazole
NCL (human) tPGkkGAtPGkALVA T113-p
NCL (mouse) tPGKKGAAQAkALVP A113
NCL (rat) TPGKKGAAQAkALVP A113
NCL iso6 (rat) TPGKKGAAQAKALVP A113
NCL (cow) TPGKKGATPGKAVVA T113
K116-ac
kkGAtPGkALVAtPG
1 37
NCL (human) kkGAtPGkALVAtPG K116-ac
NCL (mouse) KKGAAQAkALVPtPG K116-ac
NCL (rat) KKGAAQAkALVPTPG K116-ac
NCL iso6 (rat) KKGAAQAKALVPTPG K116
NCL (cow) KKGATPGKAVVATSG K116
K116-m1
kkGAtPGkALVAtPG
0 1
NCL (human) kkGAtPGkALVAtPG K116-m1
NCL (mouse) KKGAAQAKALVPtPG K116
NCL (rat) KKGAAQAKALVPTPG K116
NCL iso6 (rat) KKGAAQAKALVPTPG K116
NCL (cow) KKGATPGKAVVATSG K116
K116-ub
kkGAtPGkALVAtPG
0 2
NCL (human) kkGAtPGkALVAtPG K116-ub
NCL (mouse) KKGAAQAKALVPtPG K116
NCL (rat) KKGAAQAKALVPTPG K116
NCL iso6 (rat) KKGAAQAKALVPTPG K116
NCL (cow) KKGATPGKAVVATSG K116
T121-p
PGkALVAtPGkkGAA
Upstream
2 61
Kinase, in vitro:
  • CDC7 (human)
  • CDK1 (human)
  • CDK2 (human)
Treatment
  • EGF
  • ischemia
  • MG132_withdrawal
  • nocodazole
  • ZK-Thiazolidinone
NCL (human) PGkALVAtPGkkGAA T121-p
NCL (mouse) QAkALVPtPGkKGAA T121-p
NCL (rat) QAkALVPTPGKKGAV T121
NCL iso6 (rat) QAKALVPTPGKKGAV T121
NCL (cow) PGKAVVATSGKKGAA T121
K124-ac
ALVAtPGkkGAAIPA
1 193
NCL (human) ALVAtPGkkGAAIPA K124-ac
NCL (mouse) ALVPtPGkKGAATPA K124-ac
NCL (rat) ALVPTPGKKGAVTPA K124
NCL iso6 (rat) ALVPTPGKKGAVTPA K124
NCL (cow) AVVATSGKKGAATPG K124
K124-ub
ALVAtPGkkGAAIPA
0 2
NCL (human) ALVAtPGkkGAAIPA K124-ub
NCL (mouse) ALVPtPGKKGAATPA K124
NCL (rat) ALVPTPGKKGAVTPA K124
NCL iso6 (rat) ALVPTPGKKGAVTPA K124
NCL (cow) AVVATSGKKGAATPG K124
K124-sc
ALVAtPGkkGAAIPA
0 1
NCL (human) ALVAtPGkkGAAIPA K124-sc
NCL (mouse) ALVPtPGKKGAATPA K124
NCL (rat) ALVPTPGKKGAVTPA K124
NCL iso6 (rat) ALVPTPGKKGAVTPA K124
NCL (cow) AVVATSGKKGAATPG K124
K125-ac
LVAtPGkkGAAIPAk
1 2
NCL (human) LVAtPGkkGAAIPAk K125-ac
NCL (mouse) LVPtPGkKGAATPAK K125
NCL (rat) LVPTPGKKGAVTPAK K125
NCL iso6 (rat) LVPTPGKKGAVTPAK K125
NCL (cow) VVATSGKKGAATPGK K125
K132-ac
kGAAIPAkGAkNGKN
0 3
NCL (human) kGAAIPAkGAkNGKN K132-ac
NCL (mouse) KGAATPAKGAKNGKN K132
NCL (rat) KGAVTPAKGAKNGKN K132
NCL iso6 (rat) KGAVTPAKGAKNGKN K132
NCL (cow) KGAATPGKGAKNGKN K132
K132-m1
kGAAIPAkGAkNGKN
0 3
NCL (human) kGAAIPAkGAkNGKN K132-m1
NCL (mouse) KGAATPAKGAKNGKN K132
NCL (rat) KGAVTPAKGAKNGKN K132
NCL iso6 (rat) KGAVTPAKGAKNGKN K132
NCL (cow) KGAATPGKGAKNGKN K132
K135-ac
AIPAkGAkNGKNAKK
1 1
NCL (human) AIPAkGAkNGKNAKK K135-ac
NCL (mouse) ATPAKGAKNGKNAKK K135
NCL (rat) VTPAKGAKNGKNAKK K135
NCL iso6 (rat) VTPAKGAKNGKNAKK K135
NCL (cow) ATPGKGAKNGKNAKK K135
S145-p
KNAKKEDsDEEEDDD
Downstream
1 151
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • cell cycle regulation
  • cell growth, induced
NCL (human) KNAKKEDsDEEEDDD S145-p
NCL (mouse) KNAKKEDsDEDEDEE S145-p
NCL (rat) KNAKKEDsDEDEDEE S145-p
NCL iso6 (rat) KNAKKEDSDEDEDEE S145
NCL (cow) KNAKKEDSDEEDEDD S145
S153-p
DEEEDDDsEEDEEDD
Upstream
Downstream
1 148
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • cell cycle regulation
  • cell growth, induced
Treatment
  • dasatinib
NCL (human) DEEEDDDsEEDEEDD S153-p
NCL (mouse) DEEDEDDsDEDEDDE S157-p
NCL (rat) DEEDEDDsDEDEDEE S157-p
NCL iso6 (rat) DEEDEDDSDEDEDEE S157
NCL (cow) DEEDEDDSEEEDDDD S153
-
gap
0 1
NCL (human) gap -
NCL (mouse) PPIVKGVKPAKAAPA K178
NCL (rat) PPVVKGVkPAKAAPA K176-ac
NCL iso6 (rat) PPVVKGVKPAKAAPA K176
NCL (cow) EDEPAVRKAAAAFGA K170
S184-p
AAAAAPAsEDEDDED
Downstream
2 54
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • cell cycle regulation
  • cell growth, induced
NCL (human) AAAAAPAsEDEDDED S184-p
NCL (mouse) AAPAAPAsEDEEDDE S189-p
NCL (rat) AAPAAPAsEDEDEED S187-p
NCL iso6 (rat) AAPAAPAsEDEDEED S187-p
NCL (cow) AFGAAPATDDEDDED T181
S206-p
DDDEEDDsEEEAMEt
Downstream
2 59
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • cell cycle regulation
  • cell growth, induced
NCL (human) DDDEEDDsEEEAMEt S206-p
NCL (mouse) DEEEEDDsEEEVMEI S212-p
NCL (rat) EEEEEDDsEEEVMEI S213-p
NCL iso6 (rat) EEEEEDDsEEEVMEI S214-p
NCL (cow) DEEDEDDSEEEPMEI S210
T213-p
sEEEAMEttPAKGKK
0 3
NCL (human) sEEEAMEttPAKGKK T213-p
NCL (mouse) sEEEVMEITTAKGKK I219
NCL (rat) sEEEVMEITPAKGKK I220
NCL iso6 (rat) sEEEVMEITPAKGKK I221
NCL (cow) SEEEPMEIVPAKGKK I217
T214-p
EEEAMEttPAKGKKA
0 5
NCL (human) EEEAMEttPAKGKKA T214-p
NCL (mouse) EEEVMEITTAKGKKT T220
NCL (rat) EEEVMEITPAKGKKT T221
NCL iso6 (rat) EEEVMEITPAKGKKT T222
NCL (cow) EEEPMEIVPAKGKKA V218
K223-ac
AKGKKAAkVVPVKAK
0 1
NCL (human) AKGKKAAkVVPVKAK K223-ac
NCL (mouse) KGKKTPAKVVPMKAK K230
NCL (rat) KGKKTPAKVVPVKAK K231
NCL iso6 (rat) KGKKTPAKVVPVKAK K232
NCL (cow) KGKKAPVKAVPVKAK K228
K223-ub
AKGKKAAkVVPVKAK
0 1
NCL (human) AKGKKAAkVVPVKAK K223-ub
NCL (mouse) KGKKTPAKVVPMKAK K230
NCL (rat) KGKKTPAKVVPVKAK K231
NCL iso6 (rat) KGKKTPAKVVPVKAK K232
NCL (cow) under review -
K223-sm
AKGKKAAkVVPVKAK
0 1
NCL (human) AKGKKAAkVVPVKAK K223-sm
NCL (mouse) KGKKTPAKVVPMKAK K230
NCL (rat) KGKKTPAKVVPVKAK K231
NCL iso6 (rat) KGKKTPAKVVPVKAK K232
NCL (cow) KGKKAPVKAVPVKAK K228
N231
VVPVKAKNVAEDEDE
0 1
NCL (human) VVPVKAKNVAEDEDE N231
NCL (mouse) VVPMKAKsVAEEEDD S238-p
NCL (rat) VVPVKAKSVAEEEED S239
NCL iso6 (rat) VVPVKAKSVAEEEED S240
NCL (cow) AVPVKAKSTAEDEDE S236
K294-ac
QKAAPEAkKQkVEGt
0 1
NCL (human) QKAAPEAkKQkVEGt K294-ac
NCL (mouse) QKEAPEAKKQKVEGs K296
NCL (rat) QKEAPEAKKQKIEGs K298
NCL iso6 (rat) QKEAPEAKKQKIEGS K299
NCL (cow) QKAAPEAKKQKVEGT K304
K294-sm
QKAAPEAkKQkVEGt
1 0
NCL (human) QKAAPEAkKQkVEGt K294-sm
NCL (mouse) QKEAPEAKKQKVEGs K296
NCL (rat) QKEAPEAKKQKIEGs K298
NCL iso6 (rat) QKEAPEAKKQKIEGS K299
NCL (cow) QKAAPEAKKQKVEGT K304
K297-ac
APEAkKQkVEGtEPt
0 1
NCL (human) APEAkKQkVEGtEPt K297-ac
NCL (mouse) APEAKKQKVEGsEPt K299
NCL (rat) APEAKKQKIEGsEPT K301
NCL iso6 (rat) APEAKKQKIEGSEPT K302
NCL (cow) APEAKKQKVEGTEPT K307
K297-sm
APEAkKQkVEGtEPt
0 1
NCL (human) APEAkKQkVEGtEPt K297-sm
NCL (mouse) APEAKKQKVEGsEPt K299
NCL (rat) APEAKKQKIEGsEPT K301
NCL iso6 (rat) APEAKKQKIEGSEPT K302
NCL (cow) APEAKKQKVEGTEPT K307
T301-p
kKQkVEGtEPttAFN
0 11
NCL (human) kKQkVEGtEPttAFN T301-p
NCL (mouse) KKQKVEGsEPttPFN S303-p
NCL (rat) KKQKIEGsEPTTPFN S305-p
NCL iso6 (rat) KKQKIEGSEPTTPFN S306
NCL (cow) KKQKVEGTEPTTSFN T311
T304-p
kVEGtEPttAFNLFV
0 3
NCL (human) kVEGtEPttAFNLFV T304-p
NCL (mouse) KVEGsEPttPFNLFI T306-p
NCL (rat) KIEGsEPTTPFNLFI T308
NCL iso6 (rat) KIEGSEPTTPFNLFI T309
NCL (cow) KVEGTEPTTSFNLFV T314
T305-p
VEGtEPttAFNLFVG
0 7
NCL (human) VEGtEPttAFNLFVG T305-p
NCL (mouse) VEGsEPttPFNLFIG T307-p
NCL (rat) IEGsEPTTPFNLFIG T309
NCL iso6 (rat) IEGSEPTTPFNLFIG T310
NCL (cow) VEGTEPTTSFNLFVG T315
K318-ac
VGNLNFNkSAPELkt
0 2
NCL (human) VGNLNFNkSAPELkt K318-ac
NCL (mouse) IGNLNPNKSVNELkF K320
NCL (rat) IGNLNPNKSVAELKV K322
NCL iso6 (rat) IGNLNPNKSVAELKV K323
NCL (cow) VGNLNFNKSAPELKT K328
K318-ub
VGNLNFNkSAPELkt
0 6
NCL (human) VGNLNFNkSAPELkt K318-ub
NCL (mouse) IGNLNPNkSVNELkF K320-ub
NCL (rat) IGNLNPNKSVAELKV K322
NCL iso6 (rat) IGNLNPNKSVAELKV K323
NCL (cow) VGNLNFNKSAPELKT K328
K324-ub
NkSAPELktGIsDVF
0 17
NCL (human) NkSAPELktGIsDVF K324-ub
NCL (mouse) NkSVNELkFAISELF K326-ub
NCL (rat) NKSVAELKVAISELF K328
NCL iso6 (rat) NKSVAELKVAISELF K329
NCL (cow) NKSAPELKTGISDLF K334
K324-sm
NkSAPELktGIsDVF
0 3
NCL (human) NkSAPELktGIsDVF K324-sm
NCL (mouse) NkSVNELKFAISELF K326
NCL (rat) NKSVAELKVAISELF K328
NCL iso6 (rat) NKSVAELKVAISELF K329
NCL (cow) NKSAPELKTGISDLF K334
T325-p
kSAPELktGIsDVFA
0 1
NCL (human) kSAPELktGIsDVFA T325-p
NCL (mouse) kSVNELkFAISELFA F327
NCL (rat) KSVAELKVAISELFA V329
NCL iso6 (rat) KSVAELKVAISELFA V330
NCL (cow) KSAPELKTGISDLFA T335
S328-p
PELktGIsDVFAkND
1 3
NCL (human) PELktGIsDVFAkND S328-p
NCL (mouse) NELkFAISELFAkND S330
NCL (rat) AELKVAISELFAKND S332
NCL iso6 (rat) AELKVAISELFAKND S333
NCL (cow) PELKTGISDLFAKND S338
K333-ac
GIsDVFAkNDLAVVD
0 1
NCL (human) GIsDVFAkNDLAVVD K333-ac
NCL (mouse) AISELFAKNDLAVVD K335
NCL (rat) AISELFAKNDLAAVD K337
NCL iso6 (rat) AISELFAKNDLAAVD K338
NCL (cow) GISDLFAKNDLAVVD K343
K333-m1
GIsDVFAkNDLAVVD
0 1
NCL (human) GIsDVFAkNDLAVVD K333-m1
NCL (mouse) AISELFAKNDLAVVD K335
NCL (rat) AISELFAKNDLAAVD K337
NCL iso6 (rat) AISELFAKNDLAAVD K338
NCL (cow) GISDLFAKNDLAVVD K343
K333-ub
GIsDVFAkNDLAVVD
0 32
NCL (human) GIsDVFAkNDLAVVD K333-ub
NCL (mouse) AISELFAkNDLAVVD K335-ub
NCL (rat) AISELFAKNDLAAVD K337
NCL iso6 (rat) AISELFAKNDLAAVD K338
NCL (cow) GISDLFAKNDLAVVD K343
R342-m1
DLAVVDVrIGMTRkF
0 1
NCL (human) DLAVVDVrIGMTRkF R342-m1
NCL (mouse) DLAVVDVRtGtNRkF R344
NCL (rat) DLAAVDVRTGTNRKF R346
NCL iso6 (rat) DLAAVDVRTGTNRKF R347
NCL (cow) DLAVVDVRIGVSRKF R352
I343
LAVVDVrIGMTRkFG
0 1
NCL (human) LAVVDVrIGMTRkFG I343
NCL (mouse) LAVVDVRtGtNRkFG T345-p
NCL (rat) LAAVDVRTGTNRKFG T347
NCL iso6 (rat) LAAVDVRTGTNRKFG T348
NCL (cow) LAVVDVRIGVSRKFG I353
M345
VVDVrIGMTRkFGyV
0 1
NCL (human) VVDVrIGMTRkFGyV M345
NCL (mouse) VVDVRtGtNRkFGYV T347-p
NCL (rat) AVDVRTGTNRKFGYV T349
NCL iso6 (rat) AVDVRTGTNRKFGYV T350
NCL (cow) VVDVRIGVSRKFGYV V355
K348-ac
VrIGMTRkFGyVDFE
0 8
NCL (human) VrIGMTRkFGyVDFE K348-ac
NCL (mouse) VRtGtNRkFGYVDFE K350-ac
NCL (rat) VRTGTNRKFGYVDFE K352
NCL iso6 (rat) VRTGTNRKFGYVDFE K353
NCL (cow) VRIGVSRKFGYVDFE K358
K348-ub
VrIGMTRkFGyVDFE
Upstream
0 5
Treatment
  • MG132
NCL (human) VrIGMTRkFGyVDFE K348-ub
NCL (mouse) VRtGtNRKFGYVDFE K350
NCL (rat) VRTGTNRKFGYVDFE K352
NCL iso6 (rat) VRTGTNRKFGYVDFE K353
NCL (cow) VRIGVSRKFGYVDFE K358
Y351-p
GMTRkFGyVDFEsAE
0 1
NCL (human) GMTRkFGyVDFEsAE Y351-p
NCL (mouse) GtNRkFGYVDFEsAE Y353
NCL (rat) GTNRKFGYVDFESAE Y355
NCL iso6 (rat) GTNRKFGYVDFESAE Y356
NCL (cow) GVSRKFGYVDFESAE Y361
S356-p
FGyVDFEsAEDLEkA
0 12
NCL (human) FGyVDFEsAEDLEkA S356-p